Patent 8946405 was granted and assigned to ProLynx on February, 2015 by the United States Patent and Trademark Office.
The invention relates to solid supports useful in medical applications that provide controlled release of drugs, such as peptides, nucleic acids and small molecules. The drugs are covalently coupled to the solid support through a linkage that releases the drug or a prodrug through controlled beta elimination.